Latest period
$521.40M
YoY change
+63.3%
5Y CAGR
+5.2%
Peak year (2022)
$894.30M
Latest annual
$791.30M
Cash on Hand history chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: $791.30M
Cash on Hand growth chart for West Pharmaceutical Services (WST) from 1985 to 2025
Latest: +63.3%
Cash on Hand history table for West Pharmaceutical Services (WST) from 1985 to 2025
| 2025 | $791.30M | +63.3% | +$306.70M | ||
| 2024 | $484.60M | -43.2% | −$369.30M | ||
| 2023 | $853.90M | -4.5% | −$40.40M | ||
| 2022 | $894.30M | +17.3% | +$131.70M | ||
| 2021 | $762.60M | +23.9% | +$147.10M | ||
| 2020 | $615.50M | +40.2% | +$176.40M | ||
| 2019 | $439.10M | +30.1% | +$101.70M | ||
| 2018 | $337.40M | +43.0% | +$101.50M | ||
| 2017 | $235.90M | +16.2% | +$32.90M | ||
| 2016 | $203.00M | -26.1% | −$71.60M | ||
| 2015 | $274.60M | +7.6% | +$19.30M | ||
| 2014 | $255.30M | +7.5% | +$17.80M | ||
| 2013 | $237.50M | +36.3% | +$63.20M | ||
| 2012 | $174.30M | +89.9% | +$82.50M | ||
| 2011 | $91.80M | -16.7% | −$18.40M | ||
| 2010 | $110.20M | +32.6% | +$27.10M | ||
| 2009 | $83.10M | -9.2% | −$8.40M | ||
| 2008 | $91.50M | -29.3% | −$37.90M | ||
| 2007 | $129.40M | +174.7% | +$82.30M | ||
| 2006 | $47.10M | -3.5% | −$1.70M | ||
| 2005 | $48.80M | -29.1% | −$20.00M | ||
| 2004 | $68.80M | +82.0% | +$31.00M | ||
| 2003 | $37.80M | +13.9% | +$4.60M | ||
| 2002 | $33.20M | -21.1% | −$8.90M | ||
| 2001 | $42.10M | -1.4% | −$600.00K | ||
| 2000 | $42.70M | -5.7% | −$2.60M | ||
| 1999 | $45.30M | +44.7% | +$14.00M | ||
| 1998 | $31.30M | -40.2% | −$21.00M | ||
| 1997 | $52.30M | +90.9% | +$24.90M | ||
| 1996 | $27.40M | +57.5% | +$10.00M | ||
| 1995 | $17.40M | -36.0% | −$9.80M | ||
| 1994 | $27.20M | +423.1% | +$22.00M | ||
| 1993 | $5.20M | +73.3% | +$2.20M | ||
| 1992 | $3.00M | +11.1% | +$300.00K | ||
| 1991 | $2.70M | +22.7% | +$500.00K | ||
| 1990 | $2.20M | +37.5% | +$600.00K | ||
| 1989 | $1.60M | -68.6% | −$3.50M | ||
| 1988 | $5.10M | -59.8% | −$7.60M | ||
| 1987 | $12.70M | +71.6% | +$5.30M | ||
| 1986 | $7.40M | -12.9% | −$1.10M | ||
| 1985 | $8.50M | — | — |
- 2025$791.30M+63.3%
- 2024$484.60M-43.2%
- 2023$853.90M-4.5%
- 2022$894.30M+17.3%
- 2021$762.60M+23.9%
- 2020$615.50M+40.2%
- 2019$439.10M+30.1%
- 2018$337.40M+43.0%
- 2017$235.90M+16.2%
- 2016$203.00M-26.1%
- 2015$274.60M+7.6%
- 2014$255.30M+7.5%
- 2013$237.50M+36.3%
- 2012$174.30M+89.9%
- 2011$91.80M-16.7%
- 2010$110.20M+32.6%
- 2009$83.10M-9.2%
- 2008$91.50M-29.3%
- 2007$129.40M+174.7%
- 2006$47.10M-3.5%
- 2005$48.80M-29.1%
- 2004$68.80M+82.0%
- 2003$37.80M+13.9%
- 2002$33.20M-21.1%
- 2001$42.10M-1.4%
- 2000$42.70M-5.7%
- 1999$45.30M+44.7%
- 1998$31.30M-40.2%
- 1997$52.30M+90.9%
- 1996$27.40M+57.5%
- 1995$17.40M-36.0%
- 1994$27.20M+423.1%
- 1993$5.20M+73.3%
- 1992$3.00M+11.1%
- 1991$2.70M+22.7%
- 1990$2.20M+37.5%
- 1989$1.60M-68.6%
- 1988$5.10M-59.8%
- 1987$12.70M+71.6%
- 1986$7.40M-12.9%
- 1985$8.50M—
Cash on Hand values are taken from West Pharmaceutical Services's reported balance sheets (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
About Cash on Hand at West Pharmaceutical Services (WST)
According to West Pharmaceutical Services's latest reported financial statements, the company's latest reported cash and short-term investments is $521.40M. Cash on hand here is cash, cash equivalents, and short-term investments reported at the end of each period — the most liquid assets on the balance sheet. Compare with total debt for net leverage and total assets for the share of assets held in cash.
Headline figure above is from the reporting period ending (reported ). Chart and table below cover the full reported history back to .
West Pharmaceutical Services (WST) most recent annual cash and short-term investments stands at $791.30M (2025) – surged 63.3% year-over-year.
West Pharmaceutical Services cash and short-term investments compound annual growth for the 2020–2025 (5 years) window is +5.2%, with mixed annual results across the window.
West Pharmaceutical Services cash and short-term investments declined from $894.30M in 2022 to $791.30M in 2025, a 11.5% drawdown.
$894.30M stands as the all-time-high annual cash and short-term investments, posted in 2022, against a low of $1.60M during 1989.
West Pharmaceutical Services Cash on Hand by Year
West Pharmaceutical Services Cash on Hand 2025: $791.30M
West Pharmaceutical Services posted cash and short-term investments of $791.30M in 2025, surged 63.3% from 2024.
West Pharmaceutical Services Cash on Hand 2024: $484.60M
In 2024, West Pharmaceutical Services reported cash and short-term investments of $484.60M, plunged 43.2% below 2023.
West Pharmaceutical Services Cash on Hand 2023: $853.90M
West Pharmaceutical Services cash and short-term investments in 2023 was $853.90M, edged down 4.5% below 2022.
West Pharmaceutical Services Cash on Hand 2022: $894.30M
2022's cash and short-term investments for West Pharmaceutical Services came in at $894.30M, grew 17.3% from 2021. This figure represents the highest annual value in the available history.
West Pharmaceutical Services Cash on Hand 2021: $762.60M
West Pharmaceutical Services cash and short-term investments in 2021 was $762.60M.
See more financial history for West Pharmaceutical Services (WST).
Sector peers by Cash on Hand
Healthcare peers of West Pharmaceutical Services (WST), ranked by their latest cash and short-term investments
| $28.12B | |
| $20.10B | |
| $14.56B | |
| $9.13B | |
| $7.27B | |
| $5.74B | |
| $5.26B | |
| $4.24B |
- $28.12B
- $20.10B
- $14.56B
- $9.13B
- $7.27B
- $5.74B
- $5.26B
- $4.24B
Frequently asked questions
West Pharmaceutical Services (WST) Key Financials
Charts, filings, and peer comparison for every metric
Explore more
Deep-dives across the income statement, cash flow, capital return, and valuation